We helped a client achieve their novel therapeutic product development and commercialization goals. The company was recently acquired for$265 MM; culminating in development, licensing agreement and a deferred Merger Agreement.
- Due Diligence: Products, Compounds, Process, Supply Chain
- Formulation, Development, Manufacturing and Commercialization Strategies
- Short- and Long-term Capital Planning
- Risk Assessment
- Front-end Investment Studies
- Feasibility Studies
